Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.

Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA.

Cancer. 2010 Apr 1;116(7):1776-82. doi: 10.1002/cncr.24957.

PMID:
20143438
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A phase I/II trial of vandetanib for patients with recurrent malignant glioma.

Kreisl TN, McNeill KA, Sul J, Iwamoto FM, Shih J, Fine HA.

Neuro Oncol. 2012 Dec;14(12):1519-26. doi: 10.1093/neuonc/nos265. Epub 2012 Oct 25.

PMID:
23099652
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.

Raymond E, Brandes AA, Dittrich C, Fumoleau P, Coudert B, Clement PM, Frenay M, Rampling R, Stupp R, Kros JM, Heinrich MC, Gorlia T, Lacombe D, van den Bent MJ; European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.

J Clin Oncol. 2008 Oct 1;26(28):4659-65. doi: 10.1200/JCO.2008.16.9235.

PMID:
18824712
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.

Puduvalli VK, Yung WK, Hess KR, Kuhn JG, Groves MD, Levin VA, Zwiebel J, Chang SM, Cloughesy TF, Junck L, Wen P, Lieberman F, Conrad CA, Gilbert MR, Meyers CA, Liu V, Mehta MP, Nicholas MK, Prados M; North American Brain Tumor Consortium.

J Clin Oncol. 2004 Nov 1;22(21):4282-9.

PMID:
15514370
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.

Raizer JJ, Grimm S, Chamberlain MC, Nicholas MK, Chandler JP, Muro K, Dubner S, Rademaker AW, Renfrow J, Bredel M.

Cancer. 2010 Nov 15;116(22):5297-305. doi: 10.1002/cncr.25462.

PMID:
20665891
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD.

J Clin Oncol. 2006 Aug 1;24(22):3651-6.

PMID:
16877733
[PubMed - indexed for MEDLINE]
Free Article
7.

Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.

Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.

Neuro Oncol. 2007 Jul;9(3):354-63. Epub 2007 Apr 23.

PMID:
17452651
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.

Perry JR, Rizek P, Cashman R, Morrison M, Morrison T.

Cancer. 2008 Oct 15;113(8):2152-7. doi: 10.1002/cncr.23813.

PMID:
18756530
[PubMed - indexed for MEDLINE]
Free Article
9.

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.

Tang P, Roldan G, Brasher PM, Fulton D, Roa W, Murtha A, Cairncross JG, Forsyth PA.

J Neurooncol. 2006 Jul;78(3):311-6. Epub 2006 May 19.

PMID:
16710748
[PubMed - indexed for MEDLINE]
10.

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.

Reardon DA, Quinn JA, Vredenburgh J, Rich JN, Gururangan S, Badruddoja M, Herndon JE 2nd, Dowell JM, Friedman AH, Friedman HS.

Cancer. 2005 Jan 15;103(2):329-38.

PMID:
15558802
[PubMed - indexed for MEDLINE]
Free Article
11.

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

Iwamoto FM, Lamborn KR, Robins HI, Mehta MP, Chang SM, Butowski NA, Deangelis LM, Abrey LE, Zhang WT, Prados MD, Fine HA.

Neuro Oncol. 2010 Aug;12(8):855-61. doi: 10.1093/neuonc/noq025. Epub 2010 Mar 3.

PMID:
20200024
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma.

Pan E, Yu D, Yue B, Potthast L, Chowdhary S, Smith P, Chamberlain M.

J Neurooncol. 2012 Oct;110(1):111-8. doi: 10.1007/s11060-012-0943-z. Epub 2012 Jul 26.

PMID:
22832897
[PubMed - indexed for MEDLINE]
13.

Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.

Giglio P, Dhamne M, Hess KR, Gilbert MR, Groves MD, Levin VA, Kang SL, Ictech SE, Liu V, Colman H, Conrad CA, Loghin M, de Groot J, Yung WK, Puduvalli VK.

Cancer. 2012 Jul 15;118(14):3599-606. doi: 10.1002/cncr.26663. Epub 2011 Nov 15.

PMID:
22086614
[PubMed - indexed for MEDLINE]
Free Article
14.

Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.

Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):51-7. doi: 10.1016/j.ijrobp.2010.09.008. Epub 2010 Oct 29.

PMID:
21035955
[PubMed - indexed for MEDLINE]
15.

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.

Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):57-63.

PMID:
9422558
[PubMed - indexed for MEDLINE]
16.

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, Ciampa AS, Ebbeling LG, Levy B, Drappatz J, Kesari S, Wen PY.

Neurology. 2008 Mar 4;70(10):779-87. doi: 10.1212/01.wnl.0000304121.57857.38.

PMID:
18316689
[PubMed - indexed for MEDLINE]
17.

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW.

Clin Cancer Res. 2003 Mar;9(3):981-90.

PMID:
12631596
[PubMed - indexed for MEDLINE]
Free Article
18.

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, Hess K, Kuhn J; North American Brain Tumor Consortium.

Neuro Oncol. 2006 Apr;8(2):189-93. Epub 2006 Mar 13.

PMID:
16533878
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

3D conformal radiotherapy and cisplatin for recurrent malignant glioma.

VanderSpek L, Fisher B, Bauman G, Macdonald D.

Can J Neurol Sci. 2008 Mar;35(1):57-64.

PMID:
18380278
[PubMed - indexed for MEDLINE]
20.

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

Zuniga RM, Torcuator R, Jain R, Anderson J, Doyle T, Ellika S, Schultz L, Mikkelsen T.

J Neurooncol. 2009 Feb;91(3):329-36. doi: 10.1007/s11060-008-9718-y. Epub 2008 Oct 25.

PMID:
18953493
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk